Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Bonnet

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Cancer Investigation|January 11, 1991
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology GroupL Dabich, S Dahlberg, R J Hartsock, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Archives of Internal Medicine|February 1, 1974
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamideG P Bodey, C A Coltman, E J Freireich, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Cancer Investigation|January 11, 1991
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology GroupL Dabich, S Dahlberg, R J Hartsock, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|December 1, 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experienceE M Hersh, B S Metch, F M Muggia, et al.
Archives of Internal Medicine|February 1, 1974
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamideG P Bodey, C A Coltman, E J Freireich, et al.
American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.
Pageof 4